Esmolol is a adrenergic antagonist (β2-selective blocker), useful in treating the tachycardia, postoperative hypertension & arrhythmia.
Dose: 50-500 mcg/kg/min.
Route: Intravenous
Duration of action: 20 minutes after stopping an infusion
Trade name: Brevibloc
Therapeutic uses:
Esmolol has following usage :
- Used in patients during surgery to prevent or treat tachycardia and in the treatment of supraventricular tachycardia.
- Particularly useful in severe postoperative hypertension and is a suitable agent in situations where cardiac output, heart rate, and blood pressure are increased.
- Used as class II anti-arrhythmic agent.
Side effects: Adverse effects of Esmolol are as follows:
- Dizziness, faintness,
- Hypotension,
- Diaphoresis,
- Blurred vision,
- Confusion,
- Increased sweating
- Unusual tiredness or weakness.